Amicus Therapeutics, Inc. (0HF9.L)

USD 9.86

(-1.0%)

Gross Profit Summary of Amicus Therapeutics, Inc.

  • Amicus Therapeutics, Inc.'s latest annual gross profit in 2023 was 362.03 Million USD , up 21.86% from previous year.
  • Amicus Therapeutics, Inc.'s latest quarterly gross profit in 2024 Q2 was 113.22 Million USD , up 19.59% from previous quarter.
  • Amicus Therapeutics, Inc. reported a annual gross profit of 290.63 Million USD in annual gross profit 2022, up 7.23% from previous year.
  • Amicus Therapeutics, Inc. reported a annual gross profit of 271.04 Million USD in annual gross profit 2021, up 17.93% from previous year.
  • Amicus Therapeutics, Inc. reported a quarterly gross profit of 94.68 Million USD for 2024 Q1, down -6.79% from previous quarter.
  • Amicus Therapeutics, Inc. reported a quarterly gross profit of 101.57 Million USD for 2023 Q4, up 8.57% from previous quarter.

Annual Gross Profit Chart of Amicus Therapeutics, Inc. (2023 - 2003)

Historical Annual Gross Profit of Amicus Therapeutics, Inc. (2023 - 2003)

Year Gross Profit Gross Profit Growth
2023 362.03 Million USD 21.86%
2022 290.63 Million USD 7.23%
2021 271.04 Million USD 17.93%
2020 229.84 Million USD 43.41%
2019 160.27 Million USD 108.58%
2018 76.84 Million USD 150.35%
2017 30.69 Million USD 644.1%
2016 4.12 Million USD 325.04%
2015 -1.83 Million USD -249.75%
2014 1.22 Million USD 109.32%
2013 -13.12 Million USD -567.8%
2012 -1.96 Million USD -109.17%
2011 21.43 Million USD 2224.73%
2010 922 Thousand USD -98.57%
2009 64.35 Million USD 330.0%
2008 14.96 Million USD 738.96%
2007 1.78 Million USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%

Peer Gross Profit Comparison of Amicus Therapeutics, Inc.

Name Gross Profit Gross Profit Difference
Editas Medicine, Inc. -99.52 Million USD 463.747%
Dynavax Technologies Corporation 182.11 Million USD -98.79%
Supernus Pharmaceuticals, Inc. 523.74 Million USD 30.876%
Perrigo Company plc 1.68 Billion USD 78.456%
Illumina, Inc. 2.74 Billion USD 86.806%
Thermo Fisher Scientific Inc. 15.22 Billion USD 97.622%
Iovance Biotherapeutics, Inc. -9.56 Million USD 3884.549%
Walgreens Boots Alliance, Inc. 26.52 Billion USD 98.635%
IQVIA Holdings Inc. 5.23 Billion USD 93.09%
Heron Therapeutics, Inc. 10.04 Million USD -3505.158%
Regeneron Pharmaceuticals, Inc. 11.3 Billion USD 96.797%
Unity Biotechnology, Inc. -19.69 Million USD 1937.809%
Waters Corporation 1.76 Billion USD 79.444%
Biogen Inc. 7.3 Billion USD 95.042%
Sangamo Therapeutics, Inc. -45.32 Million USD 898.742%
Evolus, Inc. 140.52 Million USD -157.625%
Adicet Bio, Inc. -6.09 Million USD 6036.865%
Cara Therapeutics, Inc. 14.79 Million USD -2347.141%
bluebird bio, Inc. -4.03 Million USD 9083.375%
Esperion Therapeutics, Inc. 73.06 Million USD -395.477%
FibroGen, Inc. 128.9 Million USD -180.852%
Agilent Technologies, Inc. 3.46 Billion USD 89.552%
Corbus Pharmaceuticals Holdings, Inc. -31.16 Million USD 1261.557%
Homology Medicines, Inc. -7.22 Million USD 5108.023%
Geron Corporation -123.5 Million USD 393.135%
Alnylam Pharmaceuticals, Inc. 1.51 Billion USD 76.149%
Myriad Genetics, Inc. 476.4 Million USD 24.007%
Viking Therapeutics, Inc. -292 Thousand USD 124082.877%
Intellia Therapeutics, Inc. -398.79 Million USD 190.781%
Zoetis Inc. 5.83 Billion USD 93.794%
Abeona Therapeutics Inc. 302 Thousand USD -119777.483%
Mettler-Toledo International Inc. 2.16 Billion USD 83.309%
BioMarin Pharmaceutical Inc. 1.9 Billion USD 80.99%
Vertex Pharmaceuticals Incorporated 8.6 Billion USD 95.794%
Kala Pharmaceuticals, Inc. -303 Thousand USD 119581.848%
Ionis Pharmaceuticals, Inc. 778.51 Million USD 53.497%
Atara Biotherapeutics, Inc. -313 Thousand USD 115764.537%
Verastem, Inc. -62 Thousand USD 584019.355%
Nektar Therapeutics 53.47 Million USD -576.97%
Axsome Therapeutics, Inc. 244.53 Million USD -48.048%
Aclaris Therapeutics, Inc. -85.21 Million USD 524.838%
Sarepta Therapeutics, Inc. 1.09 Billion USD 66.877%
OPKO Health, Inc. 318.12 Million USD -13.8%
Exelixis, Inc. 1.75 Billion USD 79.403%
Neurocrine Biosciences, Inc. 1.84 Billion USD 80.403%
Corcept Therapeutics Incorporated 475.89 Million USD 23.926%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 2.21 Million USD -16244.47%
Imunon, Inc. -720 Thousand USD 50381.595%
Blueprint Medicines Corporation 236.58 Million USD -53.024%
Insmed Incorporated 239.63 Million USD -51.076%
Halozyme Therapeutics, Inc. 636.89 Million USD 43.157%
Agios Pharmaceuticals, Inc. 17.31 Million USD -1990.363%
TG Therapeutics, Inc. 219.1 Million USD -65.229%
Incyte Corporation 3.44 Billion USD 89.478%
Emergent BioSolutions Inc. 343.9 Million USD -5.272%